Clinical Trial Update: Examine Maximum Tolerated Dose and Pharmacokinetic and Pharmacodynamic Profile [Phase 1]

View source ↗

Summary

Phase 1 trial update reporting the maximum tolerated dose and pharmacokinetic/pharmacodynamic profile in solid tumors.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• CrystalGenomics investigational compound

Snippet

Sponsor: CrystalGenomics, Inc. | Conditions: Solid Tumour | Phase 1 | Status: UNKNOWN